|
Net loss per share is computed using the weighted average number of shares of Common Stock outstanding less the number of shares subject to repurchase.
The following table sets forth the computation of basic and diluted net loss per share for the periods indicated (in thousands, except share data):
| Schedule of basic and diluted net loss per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Three Months Ended
September 30,
|
|
|
Nine Months Ended
September 30,
|
|
| |
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss |
|
$ |
(23,314 |
) |
|
$ |
(26,953 |
) |
|
$ |
(74,069 |
) |
|
$ |
(50,920 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator - basic and diluted: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted average common shares outstanding |
|
|
72,572,138 |
|
|
|
66,276,223 |
|
|
|
72,415,546 |
|
|
|
61,923,661 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss per share - basic and diluted |
|
$ |
(0.32 |
) |
|
$ |
(0.41 |
) |
|
$ |
(1.02 |
) |
|
$ |
(0.82 |
) |
The following table sets forth the amounts excluded from the computation of diluted net loss per share as of September 30, 2022 and 2021 because their effect was anti-dilutive.
| Schedule of anti-dilutive net loss per share |
|
|
|
|
|
|
|
|
| |
|
September 30, |
|
| |
|
2022 |
|
|
2021 |
|
| Stock options outstanding |
|
|
7,931,652 |
|
|
|
5,773,428 |
|
| Non-vested shares of restricted stock |
|
|
6,360 |
|
|
|
345,471 |
|
| Warrants(a) |
|
|
- |
|
|
|
- |
|
| Convertible notes(a) |
|
|
- |
|
|
|
- |
|
|
(a) |
The Convertible Notes and warrants referred to in Notes 11 and 14 were also excluded on an as converted basis because their effect would have been anti-dilutive. |
|